My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Nike Q2 Earnings: Revenue Beat, EPS Beat, Sha...
FedEx Stock Rallies On Better-Than-Expected Q...
Disney Hits $2 Billion Domestic Box Office, E...
Amazon Shares Rise As Company Says Operations...
4 Micron Analysts Size Up Q1 Earnings: 'An Op...
Block Positioned For Margin Expansion And EPS...
Birkenstock's High-end Lifestyle Positioning...
Astronauts Sunita Williams, Butch Wilmore's...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    MAINZ BIOMED N V (NASDAQ: MYNZ)

    Overview
    current price
    $6.68
    $6.68
    change
    1.91 | 40.04%
    1.91 | 40.04%
    Yesterday's Close
    4.77
    open
    5.24
    volume
    0.67 M
    30d. avg volume.
    0.16 M
    1 day
    5.19 - 7.22
    52 weeks
    3.65 - 53.60
    p/e
    0.00
    beta
    0.0586
    market cap
    0.01 B
    dividend yield
    0.00%
    Industry
    -
    MYNZ by TradingView
    News and Commentary
    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (PFE 
    Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer The market for vaccines and treatments used in managing COVID-19 has shrunk by billions of dollars a year. Forced to rebuild their business, pharmaceutical companies like Pfizer...
    mRNA Is Promising A Breakthrough In Fighting Cancer When it comes to cancer, there's innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during...
    The Pharmaceutical Industry Finds Itself At A Historical Crossroads Bristol Myers Squibb (BMY
    2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front On Thursday, Merck & Co Inc (M...
    Pharma Continues Its Ongoing Battle Against Cancer Last Tuesday, Pfizer Inc (PFE
    Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine Johnson & Johnson (JNJ&...
    German Medical Companies Led 12 IPO Week November's initial public offering (IPO) market started off strong, with 12 traditional offering raising over $2 billion. However, the week ahead is expected to be explosive, wit...
    November IPO Market Starts Hot with 12 Listings Planning to Raise $3.2 Billion in the Week Ahead The initial public offering (IPO) market plans to extend its momentum heading into November, with 12 traditional offers expected to raise nearly $3.2 billion.
    StockTwits
    StockTwits
    Most Shared
    Nordstrom Q3 Sales Grow, But Analysts Remain Cautious On Stock Amid Slowing Sales And Elevated Inventory
    Warner Bros Discovery Stock Soars After Multi-Year Deal with Comcast; Comcast Shares Slide On Subscriber Loss Estimates
    Apple's iPhone 16 Stumbles On 'Intelligence' Awareness, But Pro Max Shines Bright: Analyst
    Most Popular
    Market Update: Dow, S&P 500 Climb in Best Month of 2024
    Consumer Confidence Hits 2-Year High As Recession Fears Fade: Stock Market Optimism Soars To Record High
    Nordstrom Q3 Sales Grow, But Analysts Remain Cautious On Stock Amid Slowing Sales And Elevated Inventory
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Google
    Covid19
    Tesla
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2024 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?